Antimicrobial-resistant infections
From the Journals
More than 23% of antibiotic fills deemed unnecessary
Conference Coverage
Be judicious with empiric antibiotics for febrile neutropenia
From the Journals
Single-dose zoliflodacin successfully treats uncomplicated urogenital gonorrhea
About 96% of patients with urogenital gonorrhea infection had microbiologic cure with zoliflodacin, a novel agent that inhibits DNA biosynthesis...
From the Journals
H. pylori antibiotic resistance reaches ‘alarming levels’
Resistance to clarithromycin, metronidazole, and levofloxacin reached 15% or more in almost all World Health Organization regions.
Conference Coverage
Three-drug combo proves effective against multidrug-resistant UTIs
SAN FRANCISCO – A drug combo including EDTA proved superior to meropenem in the treatment of complicated urinary tract infections.
Conference Coverage
Daptomycin/fosfomycin: A new standard for MRSA bacteremia?
Better survival was seen for MRSA bacteremia at 7 days using the combo vs. monotherapy.
Conference Coverage
Stepdown to oral ciprofloxacin looks safe in gram-negative bloodstream infections
SAN FRANCISCO – A comparison of patients with gram-negative bloodstream infections showed low 90-day treatment...
Conference Coverage
In C. difficile, metronidazole may not benefit ICU patients on vancomycin
SAN FRANCISCO – Try fecal transplant instead.
Conference Coverage
ICU infections: Chlorhexidine wipes tame MRSA, CRE
SAN FRANCISCO – Decolonization tops precautions.
Conference Coverage
Point-of-care test for respiratory viruses lowers antibiotic use
PARIS – In patients presenting with respiratory infections, a point-of-care test for viral infections has been associated with a reduction in...
News from the FDA/CDC
FDA attacks antibiotic resistance with new strategy
Four-pronged approach addresses product development, stewardship, surveillance, and science.